Norway is quietly doing something unusual with genetics. A bunch of academics and medical boffins are trying to figure out how to build a high-throughput genome sequencing (HTS) platform that serves the entire national population. The project is called the Norwegian Genetic Analysis Platform (NGAP), and is under development co-operatively by Oslo University and Oslo University Hospital. What are the implications of this for healthcare systems?